Drug Shortage Report for PDP-LEVETIRACETAM

Last updated on 2020-03-06 History
Report ID 100451
Drug Identification Number 02490439
Brand name PDP-LEVETIRACETAM
Common or Proper name LEVETIRACETAM FOR INJECTION, MFR. STD.
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) LEVETIRACETAM
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10X5mL
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-11-11
Estimated end date 2020-03-16
Actual end date 2020-03-05
Shortage status Resolved
Updated date 2020-03-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-03-06 English Compare
v9 2020-03-05 French Compare
v8 2020-03-05 English Compare
v7 2020-02-28 French Compare
v6 2020-02-28 English Compare
v5 2020-01-20 French Compare
v4 2020-01-20 English Compare
v3 2019-12-06 French Compare
v2 2019-12-06 English Compare
v1 2019-12-06 English Compare

Showing 1 to 10 of 10